
Avenue Biosciences
Menlo Park, CA, United States avenuebiosciences.com From their website, Nov 2026
Work here? Claim this listing
About
Avenue Biosciences develops protein engineering technology focused on optimizing the secretory pathway and signal peptides to improve protein yield and quality. It serves developers of biologics, including antibodies, fusion proteins, cell and gene therapies, mRNA therapies, enzymes, and AI-designed proteins. The company is based in Helsinki, Finland and Menlo Park, California.
Services
High-throughput signal peptide screening
Screens multi-thousand signal peptide libraries customized for a target protein to identify the best-performing signal peptide.
Single-chain signal peptide screening
Single-chain signal peptide screening across large libraries of variants for therapeutic proteins.
Two-chain signal peptide screening
Optimizes two different chains in combination for balanced assembly, built for formats such as antibodies.
Custom signal peptide screening
Designs bespoke screens for complex targets such as 3-chain or membrane proteins.
Secretory pathway optimization
Engineers secretion to improve production yield and product quality in biologics development.
Single-chain screening
Screens signal peptide variants for single-chain therapeutic proteins.
Two-chain screening
Optimizes two chains in combination for balanced assembly, built for formats such as antibodies.
Custom screening
Designs bespoke screens for complex targets such as three-chain or membrane proteins.
2 more services
- Screening in CHO cells
- DNA analysis
- What to send
- Target protein sequence
- Organization contact form submission
- Client objectives for the screen
Capabilities
- Assays and studies
- Peptides
- Antibodies
- CHO
- mRNA
- NGS
- HTS
12 more
- High-throughput screening
- Secretion efficiency assay
- NGS analysis
- Mass spectrometry
- SEC-MALS
- Assembly analysis
- Quality analysis
- Signal peptide screening
- Single-cell secretion assay
- Secretion titer analysis
- Intact-mass analysis
- Cleavage confirmation by mass spectrometry
- Scale and capacity
- Milliliter to liter volume
- Multi-thousand signal peptide library
- Thousands of signal peptide variants
- Therapeutic areas
- Biologics
- Protein therapeutics
- Vaccine development
- Cancer
- Infectious diseases
- Immunology
- Rare diseases
Instruments and platforms
- SEC-MALS
- Mass spectrometry
- NGS
Modalities and species
- Modalities
- Antibody
- Bispecific
- Peptide
- mRNA
- Cell therapy
- Recombinant protein
- Biosimilar
- Species and models
- CHO cells
- Mammalian protein production system
Industries served
- Biotechnology
- Life sciences
Details
- Founded
- 2024
- Based in
- Menlo Park, CA, United States
- Sites
- Helsinki, Finland
- Palo Alto, United States
- Serves
- Europe, United States, USA